Compositions And Methods For Controlling Neurotropic Viral Pathogenesis By MicroRNA Targetting Read more about Compositions And Methods For Controlling Neurotropic Viral Pathogenesis By MicroRNA Targetting US Application 61/455,261Filed on 2010-10-14
Methods For Amplification And Detection Of Prions Read more about Methods For Amplification And Detection Of Prions US Application 61/433,881Filed on 2011-01-18
Nitroimidadzole Analogs With Improved TB Activity Read more about Nitroimidadzole Analogs With Improved TB Activity US Application 60/753,781Filed on 2005-12-23
Nitroimidadzole Analogs With Improved TB Activity Read more about Nitroimidadzole Analogs With Improved TB Activity US Application 60/753,763Filed on 2005-12-23
Improved HIV Immunogens Read more about Improved HIV Immunogens US Application 61/359,738Filed on 2010-06-29
Use Of Dimethyloxalylglycine (N-methoxyoxoacetyl-glycine Methyl Ester, "DMOG") And Analogs As Inhibitors For Depletion Of The JMJD Family Of Enzymes To Prevent Herpes Simplex Virus Infections And Reactivation From Latency Read more about Use Of Dimethyloxalylglycine (N-methoxyoxoacetyl-glycine Methyl Ester, "DMOG") And Analogs As Inhibitors For Depletion Of The JMJD Family Of Enzymes To Prevent Herpes Simplex Virus Infections And Reactivation From Latency US Application 61/366,563Filed on 2010-07-22
Simian Adenoviral Vector-based Vaccines Read more about Simian Adenoviral Vector-based Vaccines US Application 61/386,994Filed on 2010-09-27
Neutralizing Antibodies to HIV-1 and their Use Read more about Neutralizing Antibodies to HIV-1 and their Use US Application 61/346,808Filed on 2010-05-20
2-nitro-6(S),7-dihydro-5H-imidazo[2,1-b] [1,3]oxazines And Their Use Against Myocobacterium Tuberculosis Read more about 2-nitro-6(S),7-dihydro-5H-imidazo[2,1-b] [1,3]oxazines And Their Use Against Myocobacterium Tuberculosis US Application 61/294,634Filed on 2010-01-13
Inhibition Of The Cellular Kinase, DNA Dependent Protein Kinase (DNA-PK), As ATherapeutic Intervention For HIV Infection Read more about Inhibition Of The Cellular Kinase, DNA Dependent Protein Kinase (DNA-PK), As ATherapeutic Intervention For HIV Infection US Application 61/329,775Filed on 2010-04-30